Evidence map›Paper›PMID 33292246›Full record

ArticleCancer cell international2020

SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis.

Yang Liu, Qinshan Li, Dongxin Tang, Mengxing Li, Peng Zhao, Wenxiu Yang, Liping Shu, Jishi Wang, Zhixu He, Yanju Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Inflammatory factors collaboratively linkFrontiers in immunology · 2025
    Review
  6. Article
  7. LncRNAJournal of biomedical research · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Long Non-Coding RNAs as "MYC Facilitators".Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yang LiuDepartment of Science and Education, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No. 71 Bao Shan North Road, Yunyan District, Guiyang, 550001, Guizhou, China. rhov66@163.com.ORCID http://orcid.org/0000-0002-4439-9119
Qinshan LiNational & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Medical University, Guiyang, 550004, Guizhou, China.
Dongxin TangDepartment of Science and Education, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No. 71 Bao Shan North Road, Yunyan District, Guiyang, 550001, Guizhou, China.
Mengxing LiDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, 550004, Guizhou, China.
Peng ZhaoDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, 550004, Guizhou, China.
Wenxiu YangDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, 550004, Guizhou, China.
Liping ShuNational & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Medical University, Guiyang, 550004, Guizhou, China.
Jishi WangDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, 550004, Guizhou, China.
Zhixu HeNational & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Medical University, Guiyang, 550004, Guizhou, China.
Yanju LiDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, 550004, Guizhou, China. nrad20@163.com.
Feiqing WangDepartment of Science and Education, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No. 71 Bao Shan North Road, Yunyan District, Guiyang, 550001, Guizhou, China. ikjo66@163.com.
Guiyang Medical University · CNGuizhou University · CN

Funding

China Postdoctoral Science Foundation 43XB3794XBChina Postdoctoral Science Foundation No.2018M640938Doctoral Foundation of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine No.GYZYYFY-BS-2018[12]Project Foundation of Guizhou Administration of Traditional Chinese Medicine NO.QZYY-2016-020Project Foundation of Guizhou Health Committee NO.gzwjkj2017-1-046Project Natural Science Foundation of Guiyang City [2019]9-2-22Project Natural Science Foundation of Guiyang City [2019]9-2-34Project Natural Science Foundation of Guiyang City [2019]9-2-45Project Natural Science Foundation of Guiyang City No.[2019]9-2-2Project Natural Science Foundation of Guizhou Province [2015]2003Project Natural Science Foundation of Guizhou Province [2017]5735Project Natural Science Foundation of Guizhou Province [2017]GZ66168Project Natural Science Foundation of Guizhou Province [2018]1015)Project Natural Science Foundation of Guizhou Province [2018]2759Project Natural Science Foundation of Guizhou Province No.[2016]1019the National Natural Science Foundation of China 31660326the National Natural Science Foundation of China 81871313the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2018 PT31048the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences No.2017 PT31042the Top Talent Foundation of the Department of Education of Guizhou Province No.[2016]074
6 · The paper itself

Abstract

backgroundColorectal adenocarcinoma (CRA) is one of the leading causes of cancer-related deaths in the world. Long non-coding RNAs (lncRNAs) have been implicated to be effective regulators in the disease course of human cancers, including CRA. Small nucleolar RNA host gene 17 (SNHG17) belongs to lncRNAs, and it has been reported in breast cancer and gastric cancer. However, the function of SNHG17 and its mechanism in CRA progression remain largely unknown. In this study, we attended to shedding some light on the role of SNHG17 in CRA.

methodsRT-qPCR was used to assess SNHG17 expression in CRA cells. CCK-8 assay, colony formation and transwell assay were carried out to detect the regulatory effect of SNHG17 silencing on CRA cell proliferation and migration. The angiogenesis of SNHG7-downregulated CRA cells was analyzed by tube formation assay. Mechanism experiments were conducted to identify the interaction between miR-23a-3p and SNHG17 or C-X-C motif chemokine ligand 12 (CXCL12).

resultsSNHG17 possessed with high expression in CRA cells. Knockdown of SNHG17 caused the inhibition on CRA cell proliferation and migration. SNHG17 promoted CRA cell proliferation and migration by sponging miR-23a-3p to upregulate CXCL12.

conclusionSNHG17 promotes the proliferation and migration of CRA cells by inhibiting miR-23a-3p to modulate CXCL12-mediated angiogenesis.

Indexed as

AngiogenesisColorectal adenocarcinomaCXCL12miR-23a-3pSNHG17

Identifiers

PMID33292246
PMCPMC7690009
OpenAlexW3110511317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.